Conjugated Linoleic Acid:
Meat and dairy products from grass-fed cows are the richest known source of another type of good fat called "conjugated linoleic acid" or CLA. When ruminants are raised on fresh pasture alone, their products contain from three to five times more CLA than products from animals fed conventional diets. (A steak from the most marbled grass-fed animals will have the most CLA ,as much of the CLA is stored in fat cells.) - Conjugated linoleic acid. A powerful anti-carcinogen from animal fat sources. - Conjugated linoleic acid content of milk from cows fed different diets.
Animal studies show that as little as 0.5 percent CLA in your diet could reduce tumors by over 50 percent, in Cancers of the Breast, Colorectal, Lung, Skin, & Stomach. - Mercola
CLA’s actions actually mimic the effect of synthetic diabetic drugs. Testing on mice with type 2 diabetes have shown CLA to improve insulin action and reduce circulating glucose. Even better, the early results from human trials are just as positive, when consuming CLA for longer than eight weeks. - Mercola
Research with humans has shown that CLA has been beneficial in lowering body fat, with even greater improvement in those who combine exercise with dietary intake of CLA. Animal research has been even more promising, with significant improvements seen in both reducing body fat and in increasing lean body mass. - Mercola
Short-term trials showed that conjugated linoleic acid may reduce body fat mass and increase lean body mass. - American Journal of Clinical Nutrition
Studies have shown that CLA could possibly be able to affect and treat some types of diabetes. According to Dr. Martha Belury at Purdue University and Dr. John Vandel Heuvel at Penn State University, CLA normalizes impaired glucose tolerance in non insulin-dependent diabetes. In earlier experiments by Houseknecht et. al., it was observed that CLA and troglitazone reversed the symptoms of diabetes in a specific diabetic animal model. Effects included decreased triglycerides, insulin and leptin, and improved glucose utilization. Belury and Vanden Heuvel conclude that CLA may represent an important agent for the treatment of Type II diabetes. - Belury MA, Mahon A, Banni S., Khan SA & Heuvel JPV